GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
CELL THERAPEUTICS (CTIC) [hlAlert]

Cell Therapeutic developing, acquiring and commercializing novel treatments for cancer. Our goal is to build a leading, vertically-integrated biopharmaceutical company with a diversified portfolio of oncology
drugs and drug candidates. The company's research and in-licensing activities are concentrated on identifying new, less toxic and more effective ways to treat cancer. The company has received fast-track designation from the FDA for this indication and expect to receive priority review, which would expedite the FDA's review of our application.
( Total: 6 Current Stock Recommendations )
CELL THERAPEUTICS   (6)
Hold 33% Buy 67%
Related companies
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Buy CTIC
down 37.60 %

Rating:
Hold CTIC

Rating:
Buy CTIC
down 14.20 %

Rating:
Buy CTIC
down 1.94 %
CELL THERAPEUTICS (CTIC) rated Buy by ROTH Capital
Friday,  Oct 26, 2012  9:25 AM ET

Rating:
Buy CTIC
down 3.20 %
CELL THERAPEUTICS (CTIC) rated Buy by ThinkEquity
Monday,  Oct 15, 2012  9:25 AM ET

Rating:
Hold CTIC
down 47.82 %

Rating:
Buy CTIC
down 47.82 %

Rating:
Hold CTIC
CELL THERAPEUTICS (CTIC) rated Hold by BWS Financial
Friday,  Mar 14, 2008  9:25 AM ET

Your Recent Stocks
SymbolLastChange
CTIC 1.21 down  -19.86 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy